112 related articles for article (PubMed ID: 2936417)
21. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial.
Post S; Kraus T; Müller-Reinartz U; Weiss C; Kortmann H; Quentmeier A; Winkler M; Husfeldt KJ; Allenberg JR
Eur J Vasc Endovasc Surg; 2001 Sep; 22(3):226-31. PubMed ID: 11506515
[TBL] [Abstract][Full Text] [Related]
22. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study.
Jensen LP; Lepäntalo M; Fossdal JE; Røder OC; Jensen BS; Madsen MS; Grenager O; Fasting H; Myhre HO; Baekgaard N; Nielsen OM; Helgstrand U; Schroeder TV
Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):44-9. PubMed ID: 17400486
[TBL] [Abstract][Full Text] [Related]
23. Peripheral reconstruction when adequate saphenous vein is lacking.
Myhre HO
Acta Chir Scand Suppl; 1985; 529():73-5. PubMed ID: 2938388
[TBL] [Abstract][Full Text] [Related]
24. The sequential femoropopliteal bypass graft. A five year experience.
Friedmann P; DeLaurentis DA; Rhee SW
Am J Surg; 1976 Apr; 131(4):452-6. PubMed ID: 1267097
[TBL] [Abstract][Full Text] [Related]
25. Revascularization of popliteal and below-knee arteries with polytetrafluoroethylene.
Christenson JT; Broomé A; Norgren L; Eklöf B
Surgery; 1985 Feb; 97(2):141-9. PubMed ID: 3969618
[TBL] [Abstract][Full Text] [Related]
26. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up.
Evans LE; Webster MW; Brooks DH; Bahnson HT
Surgery; 1981 Jan; 89(1):16-22. PubMed ID: 7466607
[TBL] [Abstract][Full Text] [Related]
27. The Dacron EXS graft: patency in femoropopliteal and femorotibial surgery.
Kremen AF; Mendez-Fernandez MA; Geis RC; Henly WS
J Cardiovasc Surg (Torino); 1986; 27(2):125-30. PubMed ID: 2936748
[TBL] [Abstract][Full Text] [Related]
28. Femoropopliteal composite dacron and autogenous vein bypass grafts. A preliminary report.
Linton RR; Wirthlin LS
Arch Surg; 1973 Nov; 107(5):748-53. PubMed ID: 4270358
[No Abstract] [Full Text] [Related]
29. Incidentally detected stenoses proximal to grafts originating below the common femoral artery: do they affect graft patency or warrant repair in asymptomatic patients?
Treiman GS; Ashrafi A; Lawrence PF
J Vasc Surg; 2000 Dec; 32(6):1180-9. PubMed ID: 11107091
[TBL] [Abstract][Full Text] [Related]
30. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
[TBL] [Abstract][Full Text] [Related]
31. Dacron or ePTFE graft for above-knee femoropopliteal bypass reconstruction. A bi-centre randomised study.
Davidovic L; Jakovljevic N; Radak D; Dragas M; Ilic N; Koncar I; Markovic D
Vasa; 2010 Feb; 39(1):77-84. PubMed ID: 20186679
[TBL] [Abstract][Full Text] [Related]
32. Revascularization of the lower limb through arterial bypass with "in-situ" saphenous vein.
Pizarro IE; Ibañez F; Salas S; Cam A
Int Angiol; 1991; 10(1):44-50. PubMed ID: 2071974
[TBL] [Abstract][Full Text] [Related]
33. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
[TBL] [Abstract][Full Text] [Related]
34. Seven-year follow-up of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts.
McAuley CE; Steed DL; Webster MW
Ann Surg; 1984 Jan; 199(1):57-60. PubMed ID: 6691731
[TBL] [Abstract][Full Text] [Related]
35. Femoral-distal bypass with in situ greater saphenous vein. Long-term results using the Mills valvulotome.
Donaldson MC; Mannick JA; Whittemore AD
Ann Surg; 1991 May; 213(5):457-64; discussion 464-5. PubMed ID: 2025066
[TBL] [Abstract][Full Text] [Related]
36. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
37. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
[TBL] [Abstract][Full Text] [Related]
38. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
[TBL] [Abstract][Full Text] [Related]
39. Early experience utilizing the in situ saphenous vein technique in 54 patients.
Strayhorn EC; Wohlgemuth S; Deuel M; Glickman MH; Hurwitz RL
J Cardiovasc Surg (Torino); 1988; 29(2):161-5. PubMed ID: 3360836
[TBL] [Abstract][Full Text] [Related]
40. Popliteal artery puncture in the assessment of patients with severe leg ischemia.
Agerskov K; Faris I; Tønnesen KH; Kristensen P; Christensen SC
Ann Surg; 1983 Dec; 198(6):771-5. PubMed ID: 6639180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
